Myths vs facts: ACTN3 and menopause

ACTN3 is a gene primarily known for its role in muscle fiber composition (fast-twitch vs. slow-twitch) and is associated with sprint and power performance. There is no robust scientific evidence linking ACTN3 variants to menopause onset, symptoms, or progression. Myths suggesting that ACTN3 testing can provide insights into menopause are largely driven by marketing from consumer DNA test companies and lack solid study support. The fact is that menopause is primarily governed by hormonal changes (declining estrogen), not muscle genetics. While muscle health can indirectly affect overall well-being during aging, a direct causal effect of ACTN3 on menopausal symptoms is not established. Individuals seeking to manage menopause should rely on evidence-based approaches such as hormone therapy, nutrition, and exercise, rather than genetic tests with questionable validity. The evidence for such claims is best categorized as marketing, not scientifically substantiated.